A new treatment for the novel coronavirus has proven highly successful in helping patients in the UK recover, according to local media on Monday. Synairgen, a company based in Southampton, south England, developed a drug taken via inhaler and have been testing it since March. The drug, called SNG001, uses ...
Russia hopes to complete trials of a coronavirus vaccine in August and produce 200 million doses with foreign partners by the end of the year, the head of its sovereign wealth fund said Monday. The Russian Direct Investment Fund (RDIF), which manages some $10 billion, is working with a government ...
